Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8763-8772
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8763
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8763
OR | 95%CI | P value1 | ||
Age | 1.005 | 0.978 | 1.034 | 0.7025 |
Female gender (vs male) | 1.521 | 0.731 | 3.164 | 0.262 |
BMI | 1.072 | 0.992 | 1.158 | 0.0797 |
Smoking | ||||
Ex-smoker (vs never smoker) | 1.07 | 0.484 | 2.366 | 0.8673 |
Current smoker (vs never smoker) | 1.311 | 0.572 | 3.007 | 0.522 |
Alcohol | ||||
Moderate (vs none to minimal) | 1.283 | 0.683 | 2.409 | 0.438 |
Heavy (vs none to minimal) | 0.925 | 0.413 | 2.075 | 0.8504 |
Medication2: Yes (vs no) | 1.055 | 0.242 | 4.598 | 0.9436 |
Endoscope type: H260 (vs H290) | 1.405 | 0.854 | 2.312 | 0.1808 |
Endoscopist experience | ||||
Expert (vs less experienced) | 0.712 | 0.403 | 1.256 | 0.2407 |
Highly expert (vs less experienced) | 0.822 | 0.434 | 1.557 | 0.5477 |
Δ Midazolam dose difference (total) (mg) | 1.213 | 1.099 | 1.338 | 0.0001 |
- Citation: Jin EH, Song JH, Lee J, Bae JH, Chung SJ. Midazolam dose is associated with recurrence of paradoxical reactions during endoscopy. World J Clin Cases 2021; 9(29): 8763-8772
- URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8763.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8763